Zakharov, Anton B. https://orcid.org/0000-0002-9120-8469
Kyrpa, Mariia https://orcid.org/0009-0002-5410-2822
Kyrychenko, Alexander V. https://orcid.org/0000-0002-6223-0990
Kovalenko, Sergiy M. https://orcid.org/0000-0003-2222-8180
Kalugin, Oleg N. https://orcid.org/0000-0003-3273-9259
Ivanov, Volodymyr V. https://orcid.org/0000-0003-2297-9048
Adamowicz, Ludwik https://orcid.org/0000-0001-9557-0484
Funding for this research was provided by:
National Research Foundation of Ukraine (Grant № 87/0062 (2021.01/0062) Molecular design, synthesis and screening of new potential antiviral pharmaceutical ingredients for the treatment of infectious diseases COVID-19, Grant № 87/0062 (2021.01/0062) Molecular design, synthesis and screening of new potential antiviral pharmaceutical ingredients for the treatment of infectious diseases COVID-19, Grant № 87/0062 (2021.01/0062) Molecular design, synthesis and screening of new potential antiviral pharmaceutical ingredients for the treatment of infectious diseases COVID-19, Grant № 87/0062 (2021.01/0062) Molecular design, synthesis and screening of new potential antiviral pharmaceutical ingredients for the treatment of infectious diseases COVID-19, Grant № 87/0062 (2021.01/0062) Molecular design, synthesis and screening of new potential antiviral pharmaceutical ingredients for the treatment of infectious diseases COVID-19)
Article History
Received: 24 October 2024
Accepted: 16 December 2024
First Online: 26 December 2024
Declarations
:
: All authors agreed to participate in this research.
: The authors declare no competing interests.